The Terri Brodeur Breast Cancer Foundation http://www.terribrodeurbreastcancerfoundation.org/ is a nonprofit organization dedicated to providing critical funding to researchers investigating breast cancer cures and patient treatment options. Terri Brodeur, the Foundation’s namesake, was diagnosed with Stage 4 Breast Cancer in June 2003. Effective treatment options did not exist to help Terri. After a two-year battle, marked by courage, grace, and dignity, at the young age of 41 years, Terri succumbed to the disease, leaving behind a beloved husband and three cherished children. The Foundation is founded on the pledge of delivering 100 percent of gross fundraising dollars to breast cancer science and has held fast to this promise since its inception. The Foundation’s Grant Program seeks to fund clinical and pre-clinical fellowships in high impact, breast cancer therapeutic research areas.
This award is intended to support PhD, MD/PhD and MD physician scientists at earlier stages of their careers to enable them to develop independent programs and compelling careers in breast cancer research. The foundation seeks to fund broadly the very best proposals across all relevant disciplines and as such focus areas can include basic, preclinical, clinical research and clinical care. The award period is two years with a 1-year interim renewal to occur upon successful completion of the year one research goals. Stipends are $50,000 per year, with the intention that all funds are strictly used for direct support of the grantee or their research program.
The foundation maintains the highest standards and thus no minimum quota of grants are made in any one year. However, given the outstanding quality of candidates requesting support since the founding of the Terri Brodeur Breast Cancer Foundation, the committee seeks to fund as many meritorious fellowships as is financially possible each year. As such, it is our expectation that the grant administrators and mentors at each institution proactively carry out prescreening of proposals or applicants as is appropriate. We ask that this occurs as an active process as it greatly enables the administration of the funds. We are happy to provide additional guidance on this last point as may be needed.